WEEKLY NEWSLETTER

Free Healthy Living Email Newsletter

Get the latest health, fitness, anti-aging, and nutrition news, plus special offers, insights and updates from Health.com!

Psoriasis Journey

Regardless of severity, patients with the often disfiguring skin condition psoriasis face an elevated risk for depression, new research suggests.

By Steven ReinbergHealthDay Reporter WEDNESDAY, Sept. 30, 2015 (HealthDay News) Two experimental drugs show promise in treating psoriasis and a related condition, psoriatic arthritis, new studies report. The drugs, brodalumab and secukinumab (Cosentyx), represent a new approach to treatment, said Michael Siegel, director of research programs at the National Psoriasis Foundation. These studies show how targeting [...]

People with psoriasis may be twice as likely to experience depression as those without the common skin condition, regardless of its severity, a new study suggests.

By Steven ReinbergHealthDay Reporter WEDNESDAY, July 8, 2015 (HealthDay News) Preliminary trial results suggest that an experimental psoriasis drug may control the chronic skin disease better than the current standard treatment. The drug, guselkumab, was compared to the commonly used medication adalimumab (Humira, Enbrel) in a study involving nearly 300 patients with plaque psoriasis. Up to 86 [...]

TUESDAY, June 16, 2015 (HealthDay News) Many patients with the skin disease psoriasis showed significant improvement when taking an experimental drug called ixekizumab, according to a late-stage, phase 3 clinical trial. The visible effects of psoriasis can have a major and life-ruining impact on peoples confidence and self-esteem, study leader Chris Griffiths, a professor of [...]

Read more from the original source:
Psoriasis Condition Center - Health.com

Comments are closed.